Evidence map›Paper›PMID 39905514›Full record

ArticleJournal of biological engineering2025

NIR-activated catechol-functionalized nanodiamond nanofibers for accelerating on-demand MRSA and E. coli biofilm eradication.

Hyeonseo Park, Tejal V Patil, Jieun Lee, Hojin Kim, Seong-Jun Cho, Ki-Taek Lim

Abstract read
In one paragraph

Article in Journal of biological engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hyeonseo Park *Department of Biosystems Engineering, Kangwon National University, Chuncheon, Gangwon-do, 24341, Republic of Korea.
Tejal V Patil *Department of Biosystems Engineering, Kangwon National University, Chuncheon, Gangwon-do, 24341, Republic of Korea.
Jieun LeeDepartment of Biosystems Engineering, Kangwon National University, Chuncheon, Gangwon-do, 24341, Republic of Korea.
Hojin KimDepartment of Biosystems Engineering, Kangwon National University, Chuncheon, Gangwon-do, 24341, Republic of Korea.
Seong-Jun ChoDepartment of Food Science and Biotechnology, Kangwon National University, Chuncheon, 24341, Republic of Korea. sj.cho@kangwon.ac.kr.
Ki-Taek LimDepartment of Biosystems Engineering, Kangwon National University, Chuncheon, Gangwon-do, 24341, Republic of Korea. ktlim@kangwon.ac.kr.

Funding

Institute of Information & Communications Technology Planning & Evaluation (IITP) IITP-2024-RS-2023-00260267Ministry of Education, KR NRF-2018R1A16A1A03025582Ministry of Education, KR RE-2023-00245155
6 · The paper itself

Abstract

The rise of antibiotic resistance has made bacterial infections a persistent global health issue. In particular, extracellular polymeric substances (EPS) secreted by bacteria limit the effectiveness of conventional antibiotics, making biofilm removal challenging. To address this, we created ND@PDA nanoparticles by coating the surface of nanodiamonds (ND) with polydopamine (PDA). These nanoparticles were then integrated into polyvinyl alcohol to fabricate PVA/ND@PDA nanofiber scaffolds, resulting in an innovative platform with enhanced photothermal, antibacterial and antibiofilm properties. Upon exposure to near-infrared (NIR) light, the scaffolds exhibited a significant photothermal activity, oxidative stress and effectively damaging key bacterial components, such as biofilm, bacterial membranes, and proteins. Additionally, the catechol groups in PDA provided strong cell adhesion and high biocompatibility on the nanofiber surface. Our research proposes a platform that not only effectively addresses antibiotic-resistant infections but also contributes to advancements in wound healing therapies by enabling controlled antibacterial action with minimal toxicity.

Indexed as

AntibacterialBiofilmCell adhesionND@PDANIRPhotothermalROS

Identifiers

PMID39905514
PMCPMC11796056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.